Tariparast, Pischtaz Adel
Brockmann, Andrés
Hartwig, Rainer
Kluge, Stefan
Grensemann, Jörn
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 22 March 2021
Accepted: 16 March 2022
First Online: 2 April 2022
Declarations
:
: Ethics Committee of the Hamburg Chamber of Physicians, Germany, Reference: PV5981, March 25, 2019. Written informed consent was obtained from patients’ legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.
: N/A.
: PAT and AB have received study support from Ambu; RH reports no conflicts of interest; SK received research support from Ambu, Daiichi Sankyo, ETView Ltd, Fisher & Paykel and Xenios. He also received lecture fees from Astra, C.R.Bard, Baxter, Biotest, Cytosorbents, Fresenius, Gilead, MSD, Pfizer, Philips and Zoll. He received consultant fees from Bayer, Fresenius, Gilead, MSD and Pfizer; JG has received research support from Infectopharm, Pfizer, Ambu, Adroit Surgical, and ETView, and consultant fees from Fresenius Medical Care, Smith Medical, Drägerwerk, and GE Healthcare.